Grifols, S.A.
ロング

Buy $GRFS - NRPicks 22 Apr

アップデート済
Grifols, S.A. is engaged in the acquisition, manufacture, preparation and sale of therapeutic products, mainly plasma derivatives. The company operates through the bioscientific, hospital, diagnostic, biosupplies and other divisions.
トレード終了: ストップロスに到達
28 Jul
Fundamental AnalysisstockideasTrend Analysis

他のメディア:

免責事項